465 related articles for article (PubMed ID: 16415915)
1. Neural stem cell proliferation is decreased in schizophrenia, but not in depression.
Reif A; Fritzen S; Finger M; Strobel A; Lauer M; Schmitt A; Lesch KP
Mol Psychiatry; 2006 May; 11(5):514-22. PubMed ID: 16415915
[TBL] [Abstract][Full Text] [Related]
2. Immunoreactivity of 43 kDa growth-associated protein is decreased in post mortem hippocampus of bipolar disorder and schizophrenia.
Tian SY; Wang JF; Bezchlibnyk YB; Young LT
Neurosci Lett; 2007 Jan; 411(2):123-7. PubMed ID: 17095155
[TBL] [Abstract][Full Text] [Related]
3. Expression of hippocampal brain-derived neurotrophic factor and its receptors in Stanley consortium brains.
Dunham JS; Deakin JF; Miyajima F; Payton A; Toro CT
J Psychiatr Res; 2009 Sep; 43(14):1175-84. PubMed ID: 19376528
[TBL] [Abstract][Full Text] [Related]
4. Differences in the cellular distribution of D1 receptor mRNA in the hippocampus of bipolars and schizophrenics.
Pantazopoulos H; Stone D; Walsh J; Benes FM
Synapse; 2004 Dec; 54(3):147-55. PubMed ID: 15452863
[TBL] [Abstract][Full Text] [Related]
5. Neuronal nitric oxide synthase (NOS-I) knockout increases the survival rate of neural cells in the hippocampus independently of BDNF.
Fritzen S; Schmitt A; Köth K; Sommer C; Lesch KP; Reif A
Mol Cell Neurosci; 2007 Jun; 35(2):261-71. PubMed ID: 17459722
[TBL] [Abstract][Full Text] [Related]
6. Hippocampal FGF-2 and FGFR1 mRNA expression in major depression, schizophrenia and bipolar disorder.
Gaughran F; Payne J; Sedgwick PM; Cotter D; Berry M
Brain Res Bull; 2006 Jul; 70(3):221-7. PubMed ID: 16861106
[TBL] [Abstract][Full Text] [Related]
7. Vesicular glutamate transporter mRNA expression in the medial temporal lobe in major depressive disorder, bipolar disorder, and schizophrenia.
Uezato A; Meador-Woodruff JH; McCullumsmith RE
Bipolar Disord; 2009 Nov; 11(7):711-25. PubMed ID: 19839996
[TBL] [Abstract][Full Text] [Related]
8. Exercise reverses ethanol inhibition of neural stem cell proliferation.
Crews FT; Nixon K; Wilkie ME
Alcohol; 2004 May; 33(1):63-71. PubMed ID: 15353174
[TBL] [Abstract][Full Text] [Related]
9. Prolonged voluntary wheel-running stimulates neural precursors in the hippocampus and forebrain of adult CD1 mice.
Bednarczyk MR; Aumont A; Décary S; Bergeron R; Fernandes KJ
Hippocampus; 2009 Oct; 19(10):913-27. PubMed ID: 19405143
[TBL] [Abstract][Full Text] [Related]
10. Upregulation of the initiating step of the kynurenine pathway in postmortem anterior cingulate cortex from individuals with schizophrenia and bipolar disorder.
Miller CL; Llenos IC; Dulay JR; Weis S
Brain Res; 2006 Feb; 1073-1074():25-37. PubMed ID: 16448631
[TBL] [Abstract][Full Text] [Related]
11. Wheel running and fluoxetine antidepressant treatment have differential effects in the hippocampus and the spinal cord.
Engesser-Cesar C; Anderson AJ; Cotman CW
Neuroscience; 2007 Feb; 144(3):1033-44. PubMed ID: 17137724
[TBL] [Abstract][Full Text] [Related]
12. Lewy body/alpha-synucleinopathy in schizophrenia and depression: a preliminary neuropathological study.
Jellinger KA
Acta Neuropathol; 2009 Apr; 117(4):423-7. PubMed ID: 19198857
[TBL] [Abstract][Full Text] [Related]
13. The p75 neurotrophin receptor regulates hippocampal neurogenesis and related behaviours.
Catts VS; Al-Menhali N; Burne TH; Colditz MJ; Coulson EJ
Eur J Neurosci; 2008 Sep; 28(5):883-92. PubMed ID: 18717734
[TBL] [Abstract][Full Text] [Related]
14. 5HTTLPR polymorphism and enlargement of the pulvinar: unlocking the backdoor to the limbic system.
Young KA; Holcomb LA; Bonkale WL; Hicks PB; Yazdani U; German DC
Biol Psychiatry; 2007 Mar; 61(6):813-8. PubMed ID: 17083920
[TBL] [Abstract][Full Text] [Related]
15. Decreased numbers of progenitor cells but no response to antidepressant drugs in the hippocampus of elderly depressed patients.
Lucassen PJ; Stumpel MW; Wang Q; Aronica E
Neuropharmacology; 2010 May; 58(6):940-9. PubMed ID: 20138063
[TBL] [Abstract][Full Text] [Related]
16. Investigation of m1/m4 muscarinic receptors in the anterior cingulate cortex in schizophrenia, bipolar disorder, and major depression disorder.
Zavitsanou K; Katsifis A; Mattner F; Huang XF
Neuropsychopharmacology; 2004 Mar; 29(3):619-25. PubMed ID: 14694353
[TBL] [Abstract][Full Text] [Related]
17. Reduction of synapsin in the hippocampus of patients with bipolar disorder and schizophrenia.
Vawter MP; Thatcher L; Usen N; Hyde TM; Kleinman JE; Freed WJ
Mol Psychiatry; 2002; 7(6):571-8. PubMed ID: 12140780
[TBL] [Abstract][Full Text] [Related]
18. Alterations in cell adhesion molecule L1 and functionally related genes in major depression: a postmortem study.
Laifenfeld D; Karry R; Klein E; Ben-Shachar D
Biol Psychiatry; 2005 Apr; 57(7):716-25. PubMed ID: 15820228
[TBL] [Abstract][Full Text] [Related]
19. NO synthase-positive striatal interneurons are decreased in schizophrenia.
Fritzen S; Lauer M; Schmitt A; Töpner T; Strobel A; Lesch KP; Reif A
Eur Neuropsychopharmacol; 2007 Sep; 17(9):595-9. PubMed ID: 17267181
[TBL] [Abstract][Full Text] [Related]
20. Growth-associated protein 43 (GAP-43) and synaptophysin alterations in the dentate gyrus of patients with schizophrenia.
Chambers JS; Thomas D; Saland L; Neve RL; Perrone-Bizzozero NI
Prog Neuropsychopharmacol Biol Psychiatry; 2005 Feb; 29(2):283-90. PubMed ID: 15694236
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
